Related Experiment Video
Updated: Jan 24, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with
Stefano Cavalieri1, Federica Perrone2, Massimo Milione2
1Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Background:
Recurrent or metastatic (R/M) skin squamous cell carcinoma (sSCC) not amenable of surgery or irradiation may benefit from systemic therapies. Epidermal growth factor receptor (EGFR) inhibitors and, more recently, immune checkpoint blockers (ICBs) showed activity in R/M sSCC. In this study, we aimed at exploring the possible role of PD-L1 expression in predicting response to anti-EGFR agents.
Methods:
Patients affected by R/M sSCC, treated with pan-HER inhibitor dacomitinib or with platinum-based chemotherapy with cetuximab (CT-cet) from 2010 to 2016, were considered. PD-L1 expression was assessed with immunohistochemistry on tumor cells (TCs) and on microenvironment (TC and tumor-infiltrating lymphocyte [IC] scores, respectively). Prognostic role of PD-L1 and the correlation with response to EGFR inhibitors and survival were analyzed.
Results:
Twenty-eight R/M sSCCs were analyzed (19 treated with dacomitinib, 9 with CT-cet). TC and IC were negative in 82 and 45% of cases, respectively; 15% sSCCs were both TC and IC positive. Progression-free survival (PFS) was longer in IC-positive cases (median 7.5 months vs. 2.1 in IC0, p = 0.02). No statistically significant differences were observed between PD-L1 expression and both overall survival and response rates.
Conclusion:
PD-L1 expression in microenvironment predicted better PFS. The combination of EGFR inhibitors and ICB could help deepening the knowledge about the interrelations between the EGFR and PD-1/PD-L1 pathways.
Insights
PD-L1 expression in the tumor microenvironment was linked to longer progression-free survival in patients with advanced skin squamous cell carcinoma treated with EGFR inhibitors. This suggests a potential biomarker for treatment response.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Advanced skin squamous cell carcinoma (sSCC) often requires systemic therapy when surgery or irradiation are not options.
- Epidermal growth factor receptor (EGFR) inhibitors and immune checkpoint blockers (ICBs) have demonstrated efficacy in R/M sSCC.
- The predictive role of PD-L1 expression in response to anti-EGFR agents in sSCC remains to be fully elucidated.
Purpose of the Study:
- To investigate the association between PD-L1 expression and treatment outcomes in patients with R/M sSCC receiving EGFR inhibitors.
- To explore the prognostic significance of PD-L1 expression on tumor cells (TCs) and tumor-infiltrating lymphocytes (ICs).
Main Methods:
- Retrospective analysis of 28 R/M sSCC patients treated with dacomitinib or chemotherapy plus cetuximab (2010-2016).
- PD-L1 expression assessed via immunohistochemistry on TCs and ICs.
- Correlation of PD-L1 status with progression-free survival (PFS), overall survival (OS), and response rates.
Main Results:
- PD-L1 expression on ICs was associated with significantly longer PFS (7.5 months vs. 2.1 months, p=0.02).
- No significant correlation was found between PD-L1 expression (TC or IC) and OS or response rates.
- A minority of cases (15%) showed positivity for both TC and IC PD-L1 expression.
Conclusions:
- PD-L1 expression in the tumor microenvironment (ICs) may serve as a predictive biomarker for improved PFS in R/M sSCC treated with EGFR inhibitors.
- Further research into the interplay between EGFR and PD-1/PD-L1 pathways, potentially through combination therapies, is warranted.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity

